|
chr4_+_14985272
|
2.210
|
NM_001135171
|
C1QTNF7
|
C1q and tumor necrosis factor related protein 7
|
|
chr11_-_85074848
|
2.113
|
NM_152723
|
CCDC89
|
coiled-coil domain containing 89
|
|
chr18_+_64616296
|
1.883
|
NM_024781
|
CCDC102B
|
coiled-coil domain containing 102B
|
|
chr3_+_189413414
|
1.810
|
NM_005578
|
LPP
|
LIM domain containing preferred translocation partner in lipoma
|
|
chr1_-_159459814
|
1.809
|
|
APOA2
|
apolipoprotein A-II
|
|
chr16_+_54070302
|
1.790
|
NM_004530
|
MMP2
|
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)
|
|
chr3_-_71376919
|
1.735
|
|
FOXP1
|
forkhead box P1
|
|
chr11_-_114880275
|
1.729
|
NM_001098517
NM_014333
|
CADM1
|
cell adhesion molecule 1
|
|
chr10_-_101831579
|
1.726
|
NM_001308
|
CPN1
|
carboxypeptidase N, polypeptide 1
|
|
chr10_+_104525877
|
1.696
|
NM_017787
|
C10orf26
|
chromosome 10 open reading frame 26
|
|
chr5_-_42847716
|
1.685
|
NM_001085486
NM_001093726
NM_005410
|
SEPP1
|
selenoprotein P, plasma, 1
|
|
chr13_+_112825113
|
1.640
|
NM_000504
|
F10
|
coagulation factor X
|
|
chr1_-_159459999
|
1.639
|
NM_001643
|
APOA2
|
apolipoprotein A-II
|
|
chr1_-_20682541
|
1.626
|
|
|
|
|
chr16_-_85099941
|
1.529
|
|
LOC400550
|
hypothetical LOC400550
|
|
chr9_+_117955890
|
1.488
|
NM_002581
|
PAPPA
|
pregnancy-associated plasma protein A, pappalysin 1
|
|
chr7_+_134483305
|
1.419
|
NM_018295
|
TMEM140
|
transmembrane protein 140
|
|
chr8_+_40130143
|
1.399
|
NM_020130
|
C8orf4
|
chromosome 8 open reading frame 4
|
|
chr17_+_9686572
|
1.348
|
|
GLP2R
|
glucagon-like peptide 2 receptor
|
|
chr12_+_119900931
|
1.324
|
NM_000545
|
HNF1A
|
HNF1 homeobox A
|
|
chr1_-_199732323
|
1.321
|
NM_001193572
|
CSRP1
|
cysteine and glycine-rich protein 1
|
|
chr3_-_58497913
|
1.320
|
NM_003500
|
ACOX2
|
acyl-CoA oxidase 2, branched chain
|
|
chr3_-_115825742
|
1.273
|
NM_001164347
|
ZBTB20
|
zinc finger and BTB domain containing 20
|
|
chr5_+_154072654
|
1.265
|
NM_015315
|
LARP1
|
La ribonucleoprotein domain family, member 1
|
|
chr7_-_139987044
|
1.255
|
|
DENND2A
|
DENN/MADD domain containing 2A
|
|
chr7_+_1543644
|
1.248
|
|
MAFK
|
v-maf musculoaponeurotic fibrosarcoma oncogene homolog K (avian)
|
|
chr7_-_95063738
|
1.197
|
NM_002612
|
PDK4
|
pyruvate dehydrogenase kinase, isozyme 4
|
|
chr2_-_233586145
|
1.193
|
|
NGEF
|
neuronal guanine nucleotide exchange factor
|
|
chr1_-_24342158
|
1.172
|
NM_021258
|
IL22RA1
|
interleukin 22 receptor, alpha 1
|
|
chr2_-_233586164
|
1.167
|
NM_019850
|
NGEF
|
neuronal guanine nucleotide exchange factor
|
|
chr11_+_73037382
|
1.162
|
NM_001130036
|
PLEKHB1
|
pleckstrin homology domain containing, family B (evectins) member 1
|
|
chr1_+_116455898
|
1.143
|
NM_152367
|
MAB21L3
|
mab-21-like 3 (C. elegans)
|
|
chr12_+_119900677
|
1.116
|
|
HNF1A
|
HNF1 homeobox A
|
|
chr16_-_56389176
|
1.104
|
NM_001130099
|
KIFC3
|
kinesin family member C3
|
|
chr17_-_6958695
|
1.102
|
|
ASGR2
|
asialoglycoprotein receptor 2
|
|
chr10_-_105411339
|
1.090
|
|
SH3PXD2A
|
SH3 and PX domains 2A
|
|
chr4_+_15038726
|
1.059
|
NM_031911
|
C1QTNF7
|
C1q and tumor necrosis factor related protein 7
|
|
chr18_-_490583
|
1.041
|
NM_130386
|
COLEC12
|
collectin sub-family member 12
|
|
chr11_+_101488380
|
1.016
|
NM_001195045
|
YAP1
|
Yes-associated protein 1
|
|
chr2_+_73973640
|
0.990
|
|
ACTG2
|
actin, gamma 2, smooth muscle, enteric
|
|
chr14_-_22358752
|
0.984
|
NM_001126106
|
SLC7A7
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 7
|
|
chr20_-_49612574
|
0.983
|
NM_001136021
|
NFATC2
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2
|
|
chr14_+_23937766
|
0.982
|
NM_025081
|
NYNRIN
|
NYN domain and retroviral integrase containing
|
|
chr2_-_134042500
|
0.981
|
NM_207363
NM_207481
|
NCKAP5
|
NCK-associated protein 5
|
|
chr2_-_192420168
|
0.981
|
NM_004657
|
SDPR
|
serum deprivation response
|
|
chr20_-_49612745
|
0.969
|
|
NFATC2
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2
|
|
chr3_-_52844274
|
0.963
|
NM_205853
|
MUSTN1
|
musculoskeletal, embryonic nuclear protein 1
|
|
chr2_-_165259334
|
0.958
|
|
COBLL1
|
COBL-like 1
|
|
chr1_-_112333192
|
0.956
|
NM_004980
NM_172198
|
KCND3
|
potassium voltage-gated channel, Shal-related subfamily, member 3
|
|
chr1_+_84402962
|
0.953
|
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta
|
|
chr2_+_73973600
|
0.953
|
NM_001615
|
ACTG2
|
actin, gamma 2, smooth muscle, enteric
|
|
chr10_+_63478974
|
0.949
|
|
ARID5B
|
AT rich interactive domain 5B (MRF1-like)
|
|
chr6_-_30151526
|
0.940
|
NM_170769
NM_025236
|
RNF39
|
ring finger protein 39
|
|
chr22_-_30018329
|
0.928
|
NM_001135911
NM_052880
|
PIK3IP1
|
phosphoinositide-3-kinase interacting protein 1
|
|
chr22_-_35835548
|
0.916
|
|
TMPRSS6
|
transmembrane protease, serine 6
|
|
chr12_-_9159707
|
0.914
|
|
A2M
|
alpha-2-macroglobulin
|
|
chr17_-_6958773
|
0.913
|
NM_001181
NM_080912
NM_080913
|
ASGR2
|
asialoglycoprotein receptor 2
|
|
chr11_+_834445
|
0.898
|
NM_001025237
|
TSPAN4
|
tetraspanin 4
|
|
chr13_-_37341859
|
0.897
|
NM_001135955
NM_001135956
NM_001135957
NM_001135958
NM_003306
NM_016179
|
TRPC4
|
transient receptor potential cation channel, subfamily C, member 4
|
|
chr16_+_66129481
|
0.887
|
|
FAM65A
|
family with sequence similarity 65, member A
|
|
chr6_+_62341966
|
0.884
|
NM_001190706
|
MTRNR2L9
|
MT-RNR2-like 9
|
|
chr2_-_192419896
|
0.882
|
|
SDPR
|
serum deprivation response
|
|
chr12_-_9159780
|
0.872
|
|
A2M
|
alpha-2-macroglobulin
|
|
chr12_+_32578513
|
0.846
|
|
FGD4
|
FYVE, RhoGEF and PH domain containing 4
|
|
chr12_-_9159742
|
0.836
|
|
A2M
|
alpha-2-macroglobulin
|
|
chr7_+_113513828
|
0.836
|
|
FOXP2
|
forkhead box P2
|
|
chr7_+_116238309
|
0.829
|
|
CAPZA2
|
capping protein (actin filament) muscle Z-line, alpha 2
|
|
chr1_-_20685314
|
0.814
|
NM_018584
|
CAMK2N1
|
calcium/calmodulin-dependent protein kinase II inhibitor 1
|
|
chr3_-_71196696
|
0.813
|
|
FOXP1
|
forkhead box P1
|
|
chr20_-_49818268
|
0.810
|
|
ATP9A
|
ATPase, class II, type 9A
|
|
chr12_+_99391681
|
0.782
|
NM_005123
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4
|
|
chr20_+_43468617
|
0.776
|
NM_001048223
NM_001048224
|
DBNDD2
|
dysbindin (dystrobrevin binding protein 1) domain containing 2
|
|
chr3_+_64645819
|
0.776
|
|
LOC100507098
|
hypothetical LOC100507098
|
|
chr3_-_114643008
|
0.769
|
NM_001164496
NM_018338
|
WDR52
|
WD repeat domain 52
|
|
chr1_-_75854281
|
0.768
|
|
SLC44A5
|
solute carrier family 44, member 5
|
|
chr20_+_44771532
|
0.767
|
NM_030777
|
SLC2A10
|
solute carrier family 2 (facilitated glucose transporter), member 10
|
|
chr20_-_49818306
|
0.766
|
NM_006045
|
ATP9A
|
ATPase, class II, type 9A
|
|
chr7_+_113513600
|
0.765
|
|
FOXP2
|
forkhead box P2
|
|
chr17_-_61655915
|
0.762
|
NM_000042
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I)
|
|
chr18_+_30544193
|
0.759
|
NM_001198941
NM_032978
|
DTNA
|
dystrobrevin, alpha
|
|
chr11_+_62893836
|
0.754
|
NM_080866
|
SLC22A9
|
solute carrier family 22 (organic anion transporter), member 9
|
|
chr12_+_99391870
|
0.750
|
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4
|
|
chr11_-_34491878
|
0.747
|
NM_001422
|
ELF5
|
E74-like factor 5 (ets domain transcription factor)
|
|
chr12_-_9159789
|
0.746
|
NM_000014
|
A2M
|
alpha-2-macroglobulin
|
|
chr16_-_28457728
|
0.743
|
|
NUPR1
|
nuclear protein, transcriptional regulator, 1
|
|
chr4_-_186693574
|
0.740
|
NM_001114107
NM_014476
|
PDLIM3
|
PDZ and LIM domain 3
|
|
chr15_-_81037554
|
0.733
|
NM_001079533
NM_001079534
NM_001079535
|
CPEB1
|
cytoplasmic polyadenylation element binding protein 1
|
|
chr2_+_176761552
|
0.732
|
NM_024501
|
HOXD1
|
homeobox D1
|
|
chr2_-_165133239
|
0.730
|
|
GRB14
|
growth factor receptor-bound protein 14
|
|
chr2_-_68400516
|
0.728
|
NM_001111101
NM_015463
|
CNRIP1
|
cannabinoid receptor interacting protein 1
|
|
chr10_+_18729518
|
0.728
|
NM_201570
|
CACNB2
|
calcium channel, voltage-dependent, beta 2 subunit
|
|
chr1_-_92124064
|
0.727
|
|
TGFBR3
|
transforming growth factor, beta receptor III
|
|
chr3_+_139636104
|
0.721
|
NM_031913
|
ESYT3
|
extended synaptotagmin-like protein 3
|
|
chr6_-_87861492
|
0.715
|
NM_000735
|
CGA
|
glycoprotein hormones, alpha polypeptide
|
|
chr17_-_43390108
|
0.710
|
NM_024320
|
PRR15L
|
proline rich 15-like
|
|
chr6_-_127822227
|
0.709
|
NM_014702
|
KIAA0408
|
KIAA0408
|
|
chr1_-_27113018
|
0.698
|
NM_021969
|
NR0B2
|
nuclear receptor subfamily 0, group B, member 2
|
|
chr1_-_1346465
|
0.675
|
NM_001145210
|
LOC441869
|
hypothetical protein LOC441869
|
|
chr14_+_22136968
|
0.669
|
NM_022060
|
ABHD4
|
abhydrolase domain containing 4
|
|
chr3_+_139636111
|
0.668
|
|
ESYT3
|
extended synaptotagmin-like protein 3
|
|
chr7_+_94377145
|
0.665
|
NM_001166161
NM_001166162
NM_001166163
|
PPP1R9A
|
protein phosphatase 1, regulatory (inhibitor) subunit 9A
|
|
chr7_+_113842470
|
0.658
|
|
FOXP2
|
forkhead box P2
|
|
chr15_-_68781662
|
0.650
|
NM_001008224
|
UACA
|
uveal autoantigen with coiled-coil domains and ankyrin repeats
|
|
chr2_-_188086612
|
0.635
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
chr10_+_123913094
|
0.634
|
NM_006997
NM_206860
|
TACC2
|
transforming, acidic coiled-coil containing protein 2
|
|
chr8_+_67096344
|
0.632
|
NM_033105
|
DNAJC5B
|
DnaJ (Hsp40) homolog, subfamily C, member 5 beta
|
|
chr7_+_136203938
|
0.625
|
NM_001006627
NM_001006630
|
CHRM2
|
cholinergic receptor, muscarinic 2
|
|
chr9_+_27099138
|
0.612
|
NM_000459
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
chr17_-_36418869
|
0.610
|
NM_031958
|
KRTAP3-1
|
keratin associated protein 3-1
|
|
chr17_+_2627099
|
0.606
|
|
RAP1GAP2
|
RAP1 GTPase activating protein 2
|
|
chr1_+_183970093
|
0.605
|
NM_031935
|
HMCN1
|
hemicentin 1
|
|
chr10_+_31650069
|
0.602
|
NM_001128128
NM_001174094
|
ZEB1
|
zinc finger E-box binding homeobox 1
|
|
chr11_+_22652894
|
0.598
|
NM_005256
|
GAS2
|
growth arrest-specific 2
|
|
chr16_-_65742323
|
0.595
|
NM_033309
|
B3GNT9
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9
|
|
chr17_+_56109940
|
0.592
|
NM_001099432
NM_017679
|
BCAS3
|
breast carcinoma amplified sequence 3
|
|
chr3_+_173043832
|
0.581
|
NM_001164436
|
TMEM212
|
transmembrane protein 212
|
|
chr9_+_133154896
|
0.580
|
NM_032728
|
PPAPDC3
|
phosphatidic acid phosphatase type 2 domain containing 3
|
|
chr9_+_139245029
|
0.579
|
NM_001177316
NM_001177317
|
SLC34A3
|
solute carrier family 34 (sodium phosphate), member 3
|
|
chr5_-_121842680
|
0.577
|
|
|
|
|
chr7_-_81237162
|
0.574
|
NM_000601
NM_001010931
NM_001010932
NM_001010933
NM_001010934
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
chr10_-_92671005
|
0.572
|
NM_014391
|
ANKRD1
|
ankyrin repeat domain 1 (cardiac muscle)
|
|
chr12_-_90100733
|
0.571
|
NM_001920
|
DCN
|
decorin
|
|
chr3_+_171621721
|
0.569
|
NM_001185056
|
CLDN11
|
claudin 11
|
|
chr11_-_76676110
|
0.568
|
NM_182833
|
GDPD4
|
glycerophosphodiester phosphodiesterase domain containing 4
|
|
chr3_-_55489973
|
0.565
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
chr11_+_22652957
|
0.563
|
|
GAS2
|
growth arrest-specific 2
|
|
chr1_-_60164912
|
0.563
|
NM_000775
|
CYP2J2
|
cytochrome P450, family 2, subfamily J, polypeptide 2
|
|
chr10_-_44794146
|
0.554
|
NM_007021
|
C10orf10
|
chromosome 10 open reading frame 10
|
|
chr21_-_38955487
|
0.550
|
NM_001136154
NM_004449
|
ERG
|
v-ets erythroblastosis virus E26 oncogene homolog (avian)
|
|
chr19_+_40322231
|
0.532
|
NM_005031
|
FXYD1
|
FXYD domain containing ion transport regulator 1
|
|
chr2_-_210726539
|
0.529
|
|
C2orf67
|
chromosome 2 open reading frame 67
|
|
chr4_+_187424336
|
0.524
|
|
F11
|
coagulation factor XI
|
|
chr7_+_28415495
|
0.523
|
|
LOC401317
|
hypothetical LOC401317
|
|
chr19_+_46417099
|
0.522
|
|
AXL
|
AXL receptor tyrosine kinase
|
|
chr13_-_109600709
|
0.520
|
|
COL4A1
|
collagen, type IV, alpha 1
|
|
chr9_+_139245197
|
0.520
|
NM_080877
|
SLC34A3
|
solute carrier family 34 (sodium phosphate), member 3
|
|
chr6_+_32229599
|
0.517
|
NM_005155
|
PPT2-EGFL8
PPT2
|
PPT2-EGFL8 read-through transcript
palmitoyl-protein thioesterase 2
|
|
chr19_+_46417117
|
0.514
|
|
AXL
|
AXL receptor tyrosine kinase
|
|
chr14_-_23653965
|
0.502
|
|
NRL
|
neural retina leucine zipper
|
|
chr14_-_93859394
|
0.500
|
NM_001756
|
SERPINA6
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6
|
|
chr5_-_44424423
|
0.499
|
NM_004465
|
FGF10
|
fibroblast growth factor 10
|
|
chr1_-_238842011
|
0.495
|
|
GREM2
|
gremlin 2
|
|
chr4_+_120167264
|
0.492
|
|
SYNPO2
|
synaptopodin 2
|
|
chr9_-_14900992
|
0.490
|
NM_144966
|
FREM1
|
FRAS1 related extracellular matrix 1
|
|
chr6_+_32229771
|
0.488
|
|
PPT2-EGFL8
PPT2
|
PPT2-EGFL8 read-through transcript
palmitoyl-protein thioesterase 2
|
|
chr2_-_101457596
|
0.488
|
NM_001145664
|
RFX8
|
regulatory factor X, 8
|
|
chr10_-_54201400
|
0.486
|
NM_000242
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
chr19_-_7244876
|
0.486
|
NM_000208
NM_001079817
|
INSR
|
insulin receptor
|
|
chr7_-_27149750
|
0.483
|
NM_019102
|
HOXA5
|
homeobox A5
|
|
chr14_+_23654161
|
0.480
|
|
DCAF11
|
DDB1 and CUL4 associated factor 11
|
|
chr19_+_46416938
|
0.478
|
NM_001699
NM_021913
|
AXL
|
AXL receptor tyrosine kinase
|
|
chr10_-_92670764
|
0.478
|
|
ANKRD1
|
ankyrin repeat domain 1 (cardiac muscle)
|
|
chr4_-_107508040
|
0.476
|
NM_001195138
|
LOC100507096
|
GTPase IMAP family member-like
|
|
chr14_+_23653848
|
0.476
|
|
DCAF11
|
DDB1 and CUL4 associated factor 11
|
|
chr4_+_120167770
|
0.474
|
|
SYNPO2
|
synaptopodin 2
|
|
chr10_+_123912930
|
0.471
|
|
TACC2
|
transforming, acidic coiled-coil containing protein 2
|
|
chr4_+_39084867
|
0.469
|
NM_175737
|
KLB
|
klotho beta
|
|
chr16_-_28457825
|
0.465
|
NM_001042483
NM_012385
|
NUPR1
|
nuclear protein, transcriptional regulator, 1
|
|
chr14_+_23653819
|
0.464
|
NM_025230
|
DCAF11
|
DDB1 and CUL4 associated factor 11
|
|
chr14_-_75517198
|
0.461
|
|
TGFB3
|
transforming growth factor, beta 3
|
|
chr2_-_188127294
|
0.460
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
chr1_+_203064397
|
0.457
|
NM_001005388
NM_001005389
NM_001160332
NM_001160333
NM_015090
|
NFASC
|
neurofascin
|
|
chr1_-_238842071
|
0.456
|
NM_022469
|
GREM2
|
gremlin 2
|
|
chr3_-_127719283
|
0.455
|
NM_001165974
NM_144639
|
UROC1
|
urocanase domain containing 1
|
|
chr8_-_93144366
|
0.455
|
NM_004349
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
|
|
chr7_-_50596238
|
0.450
|
NM_000790
|
DDC
|
dopa decarboxylase (aromatic L-amino acid decarboxylase)
|
|
chr21_-_34820916
|
0.450
|
NM_203418
|
RCAN1
|
regulator of calcineurin 1
|
|
chr19_+_46416971
|
0.447
|
|
AXL
|
AXL receptor tyrosine kinase
|
|
chr1_-_34403443
|
0.444
|
|
CSMD2
|
CUB and Sushi multiple domains 2
|
|
chr12_-_90100710
|
0.443
|
|
DCN
|
decorin
|
|
chr17_+_69939130
|
0.441
|
NM_022036
|
GPRC5C
|
G protein-coupled receptor, family C, group 5, member C
|
|
chr10_-_52315390
|
0.439
|
|
A1CF
|
APOBEC1 complementation factor
|
|
chr20_+_31059174
|
0.439
|
|
BPIL1
|
bactericidal/permeability-increasing protein-like 1
|
|
chr2_-_189752575
|
0.435
|
NM_000393
|
COL5A2
|
collagen, type V, alpha 2
|
|
chr4_+_71126376
|
0.432
|
NM_152997
|
C4orf7
|
chromosome 4 open reading frame 7
|
|
chr2_+_109909139
|
0.431
|
NM_001164463
NM_005054
|
RGPD8
RGPD5
|
RANBP2-like and GRIP domain containing 8
RANBP2-like and GRIP domain containing 5
|
|
chr19_+_46416975
|
0.429
|
|
AXL
|
AXL receptor tyrosine kinase
|
|
chr1_-_31618405
|
0.428
|
NM_004102
|
FABP3
|
fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor)
|
|
chr12_-_51629874
|
0.425
|
|
KRT8
|
keratin 8
|
|
chr15_-_58671929
|
0.422
|
NM_134262
|
RORA
|
RAR-related orphan receptor A
|
|
chr7_+_134114957
|
0.421
|
|
CALD1
|
caldesmon 1
|
|
chr1_-_60165049
|
0.419
|
|
CYP2J2
|
cytochrome P450, family 2, subfamily J, polypeptide 2
|
|
chr14_+_23653745
|
0.419
|
NM_001163484
|
DCAF11
|
DDB1 and CUL4 associated factor 11
|
|
chr1_-_177378801
|
0.417
|
NM_001136000
NM_001168239
NM_005158
|
ABL2
|
v-abl Abelson murine leukemia viral oncogene homolog 2
|
|
chr14_+_55654900
|
0.416
|
|
PELI2
|
pellino homolog 2 (Drosophila)
|
|
chr12_-_90100679
|
0.414
|
|
DCN
|
decorin
|
|
chr17_+_64922420
|
0.410
|
NM_002758
|
MAP2K6
|
mitogen-activated protein kinase kinase 6
|
|
chrX_+_49718954
|
0.408
|
NM_000084
|
CLCN5
|
chloride channel 5
|
|
chr8_-_134378630
|
0.405
|
NM_001135242
NM_006096
|
NDRG1
|
N-myc downstream regulated 1
|
|
chr11_-_10630408
|
0.404
|
NM_001098579
|
MRVI1
|
murine retrovirus integration site 1 homolog
|
|
chr16_+_52027020
|
0.403
|
|
RBL2
|
retinoblastoma-like 2 (p130)
|
|
chr12_+_120055013
|
0.402
|
NM_002562
|
P2RX7
|
purinergic receptor P2X, ligand-gated ion channel, 7
|
|
chr22_+_36286350
|
0.402
|
NM_152243
|
CDC42EP1
|
CDC42 effector protein (Rho GTPase binding) 1
|
|
chr1_-_92124201
|
0.402
|
NM_001195683
NM_003243
|
TGFBR3
|
transforming growth factor, beta receptor III
|
|
chr6_+_84619703
|
0.400
|
NM_001009994
|
RIPPLY2
|
ripply2 homolog (zebrafish)
|
|
chr2_-_180319013
|
0.397
|
NM_001113397
|
ZNF385B
|
zinc finger protein 385B
|
|
chr16_+_68516401
|
0.397
|
NM_199424
|
WWP2
|
WW domain containing E3 ubiquitin protein ligase 2
|
|
chr17_+_54763689
|
0.393
|
NM_001005404
|
YPEL2
|
yippee-like 2 (Drosophila)
|
|
chr20_+_42777298
|
0.391
|
NM_003881
|
WISP2
|
WNT1 inducible signaling pathway protein 2
|
|
chr20_+_254205
|
0.391
|
NM_006943
|
SOX12
|
SRY (sex determining region Y)-box 12
|
